Idexx Laboratories (IDXX) Tax Provisions (2009 - 2026)

Idexx Laboratories' Tax Provisions history runs 18 years deep, the most recent figure standing at $77.0 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 14.23% year-over-year to $77.0 million; the TTM figure through Mar 2026 stood at $274.3 million (up 19.54% YoY), while the FY2025 annual figure was $264.7 million, up 19.26% from the prior year.
• Tax Provisions was $77.0 million for Q1 2026 at Idexx Laboratories, up from $58.8 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $77.0 million in Q1 2026 to a low of $39.1 million in Q2 2022.
• Historically, Tax Provisions has averaged $56.5 million across 5 years, with a median of $55.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Tax Provisions declined 20.4% in 2022, then soared 57.77% in 2023.
• A 5-year view of Tax Provisions shows it stood at $41.0 million in 2022, then grew by 10.09% to $45.1 million in 2023, then decreased by 10.87% to $40.2 million in 2024, then soared by 46.12% to $58.8 million in 2025, then jumped by 30.96% to $77.0 million in 2026.
• The last three Tax Provisions figures came in at $77.0 million (Q1 2026), $58.8 million (Q4 2025), and $70.2 million (Q3 2025), per Business Quant data.